Pharming Group N.V. announced that Robert Friesen, Chief Scientific Officer and Executive Board member resigned from his role. Mr. Friesen's succession is currently under review.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8205 EUR | -0.24% | -1.38% | -20.42% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.42% | 599M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group N.V. Announces Resignation of Robert Friesen, Chief Scientific Officer and Executive Board Member